LABU vs. XBI
Compare and contrast key facts about Direxion Daily S&P Biotech Bull 3x Shares (LABU) and SPDR S&P Biotech ETF (XBI).
LABU and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LABU is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (300%). It was launched on May 28, 2015. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006. Both LABU and XBI are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LABU or XBI.
Key characteristics
| LABU | XBI | |
|---|---|---|
| YTD Return | -3.63% | 3.70% |
| 1Y Return | -11.42% | 8.01% |
| 3Y Return (Ann) | -54.20% | -9.92% |
| 5Y Return (Ann) | -32.90% | 2.38% |
| Sharpe Ratio | -0.12 | 0.32 |
| Daily Std Dev | 82.23% | 27.69% |
| Max Drawdown | -98.92% | -63.89% |
| Current Drawdown | -97.44% | -46.76% |
Correlation
The correlation between LABU and XBI is 1.00, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
LABU vs. XBI - Performance Comparison
In the year-to-date period, LABU achieves a -3.63% return, which is significantly lower than XBI's 3.70% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LABU vs. XBI - Expense Ratio Comparison
LABU has a 1.12% expense ratio, which is higher than XBI's 0.35% expense ratio.
Risk-Adjusted Performance
LABU vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LABU vs. XBI - Dividend Comparison
LABU's dividend yield for the trailing twelve months is around 0.50%, more than XBI's 0.02% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.50% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.02% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
Drawdowns
LABU vs. XBI - Drawdown Comparison
The maximum LABU drawdown since its inception was -98.92%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for LABU and XBI. For additional features, visit the drawdowns tool.
Volatility
LABU vs. XBI - Volatility Comparison
Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 20.50% compared to SPDR S&P Biotech ETF (XBI) at 6.68%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.